# Oral Nifedipine Versus Oral Labetalol

> **NCT02168309** · NA · COMPLETED · sponsor: **Cedars-Sinai Medical Center** · enrollment: 50 (actual)

## Conditions studied

- Severe Postpartum Hypertension

## Interventions

- **DRUG:** Labetalol
- **DRUG:** Nifedipine

## Key facts

- **NCT ID:** NCT02168309
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-06
- **Final completion:** 2016-05
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02168309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02168309, "Oral Nifedipine Versus Oral Labetalol". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02168309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*